Page last updated at 10:39 GMT, Monday, 2 March 2009

Cancer pain drug deals approved

A Scottish Borders company has received approval to market a cancer pain relief drug in France and Spain.

Prostrakan now hopes to be able to launch Abstral in the two countries later this year.

A spokesman for the Galashiels-based firm said it meant the drug would now be available to prescribe across "most of western Europe".

Prostrakan started marketing the product in the UK and Germany earlier this year.

Print Sponsor

US market launch for cancer patch
03 Nov 08 |  South of Scotland
Cancer patch firm secures US deal
15 Sep 08 |  South of Scotland
Borders firm nets 74m drug deal
28 Sep 06 |  South of Scotland
East European deal for drugs firm
27 Jul 06 |  South of Scotland
Scots firm announces huge US deal
14 Jul 06 |  South of Scotland

The BBC is not responsible for the content of external internet sites

Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit


Sign in

BBC navigation

Copyright © 2019 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific